| Literature DB >> 25625332 |
Luis Jaime Castro-Vega1, Eric Letouzé2, Nelly Burnichon3, Alexandre Buffet3, Pierre-Hélie Disderot1, Emmanuel Khalifa3, Céline Loriot1, Nabila Elarouci2, Aurélie Morin1, Mélanie Menara1, Charlotte Lepoutre-Lussey4, Cécile Badoual5, Mathilde Sibony6, Bertrand Dousset7, Rossella Libé8, Franck Zinzindohoue9, Pierre François Plouin10, Jérôme Bertherat8, Laurence Amar4, Aurélien de Reyniès2, Judith Favier1, Anne-Paule Gimenez-Roqueplo11.
Abstract
Pheochromocytomas and paragangliomas (PCCs/PGLs) are neural crest-derived tumours with a very strong genetic component. Here we report the first integrated genomic examination of a large collection of PCC/PGL. SNP array analysis reveals distinct copy-number patterns associated with genetic background. Whole-exome sequencing shows a low mutation rate of 0.3 mutations per megabase, with few recurrent somatic mutations in genes not previously associated with PCC/PGL. DNA methylation arrays and miRNA sequencing identify DNA methylation changes and miRNA expression clusters strongly associated with messenger RNA expression profiling. Overexpression of the miRNA cluster 182/96/183 is specific in SDHB-mutated tumours and induces malignant traits, whereas silencing of the imprinted DLK1-MEG3 miRNA cluster appears as a potential driver in a subgroup of sporadic tumours. Altogether, the complete genomic landscape of PCC/PGL is mainly driven by distinct germline and/or somatic mutations in susceptibility genes and reveals different molecular entities, characterized by a set of unique genomic alterations.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25625332 PMCID: PMC4354166 DOI: 10.1038/ncomms7044
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 17.694